These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 13947379)

  • 1. [Therapeutic experiences with Lucidril in neuropsychiatric disease pictures].
    GERSTENBRAND F; HOFF H; PROSENZ P
    Wien Med Wochenschr; 1963 Jun; 113():539-43. PubMed ID: 13947379
    [No Abstract]   [Full Text] [Related]  

  • 2. [Centrophenoxine in the treatment of confusional syndromes and intellectual deficiency].
    JACQUEL G; ROBERT G; MOREL J
    Presse Med (1893); 1963 Apr; 71():919-20. PubMed ID: 13964393
    [No Abstract]   [Full Text] [Related]  

  • 3. [LUCIDRIL (A.N.P. 235, CENTROPHENOXINE) --OBSERVATIONS ON THE EFFECT OF THE DRUG].
    ALEKSANDROWICZ J; DZIKOWSKI H
    Neurol Neurochir Psychiatr Pol; 1963; 13():97-101. PubMed ID: 14043242
    [No Abstract]   [Full Text] [Related]  

  • 4. [Observations on the use of centrophenoxine in hospital and ambulant treatment].
    HOUILLON ; SALLES ; SELIN
    Ann Med Psychol (Paris); 1963 Jun; 2():63-9. PubMed ID: 13955058
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preliminary data on results of the application of centrophenoxine (lucidril) in psychiatry].
    MARCJAN K
    Neurol Neurochir Psychiatr Pol; 1962; 12():583-9. PubMed ID: 13932879
    [No Abstract]   [Full Text] [Related]  

  • 6. [PERIMETRIC MODIFICATIONS DUE TO A.N.P. 235 IN CHRONIC ALCOHOLICS].
    BIASCI L; RONCO P; MUNICCHI L
    Rass Studi Psichiatr; 1964; 53():390-400. PubMed ID: 14236364
    [No Abstract]   [Full Text] [Related]  

  • 7. [Introductory attempt of therapeutic use of centrophenoxin-Lucidril in diabetes insipidus].
    Kostkowski A
    Przegl Lek; 1967; 23(9):701-4. PubMed ID: 4383558
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of two central nervous system stimulants, MER-22 and S.K.F. #5, on chronic blocked and withdrawn psychotic patients.
    HAGENAUER F; RUDY LH; HIMWICH HE
    Am J Psychiatry; 1957 Mar; 113(9):840. PubMed ID: 13402976
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new medicine in chemotherapy of psychoses].
    Dtsch Med Wochenschr; 1955 Dec; 80(48):1777. PubMed ID: 13285230
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study of the behavior of retarded children in the course of their treatment with ANP 235 (2-dimethylaminoethyl-p-chlorophenoxy-acetate].
    JAKAB I; BURDICK B
    Ann Med Psychol (Paris); 1963 Feb; 121(1)():193-204. PubMed ID: 13964497
    [No Abstract]   [Full Text] [Related]  

  • 11. Trial of A.N.P. 235 in disturbed severely subnormal children.
    KIRMAN BH
    J Ment Defic Res; 1961 Dec; 5():108-10. PubMed ID: 14456325
    [No Abstract]   [Full Text] [Related]  

  • 12. [Initial results concerning the action of a new psychotonic, S 186, in cases of senile intellectual deficiencies].
    SCHWEICH M; CAPRON C; CAPRON H; SANCHEZ F; TIMSIT M
    Ann Med Psychol (Paris); 1961 Dec; 119(2)():977-80. PubMed ID: 13909808
    [No Abstract]   [Full Text] [Related]  

  • 13. [THERAPEUTIC EXPERIENCES WITH VESITAN IN A MIXED GROUP OF PSYCHIATRIC PATIENTS].
    SYDATH W
    Med Klin; 1964 May; 59():902-4. PubMed ID: 14213637
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of reserpine and reserpine associated with a psychotonic in some senile psychoses].
    NEGRI F
    Arch Psicol Neurol Psichiatr; 1956; 17(2-3):441-51. PubMed ID: 13341414
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indications and limitations for the use of lucidril (ANP 235) in medical reanimation].
    MICHON P; LARCAN A; HURIET C; STREIFF F
    Rev Med Nancy; 1961 Nov; 86():1150-7. PubMed ID: 14473474
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indications and limitations of the use of Lucidril (ANP-235) in medical resuscitation].
    MICHON P; LARCAN A; HURIET C; STREIFF F
    Agressologie; 1961 Nov; 2():575-80. PubMed ID: 14473475
    [No Abstract]   [Full Text] [Related]  

  • 17. [ON THE CONTROL OF CHARCOT'S DISEASE WITH CENTROPHENOXINE (ANP 235, LUCIDRIL). STUDY ON AMYOTROPIC LATERAL SCLEROSIS. XIII].
    SERCL M; KOVARIK J
    Psychiatr Neurol (Basel); 1963; 146():55-63. PubMed ID: 14043294
    [No Abstract]   [Full Text] [Related]  

  • 18. A pharmacological report on PM-1090. (A new intravenous convulsant in treatment of psychoses).
    BERG S; ROBBINS ES
    J Neuropsychiatr; 1959; 1():32-4. PubMed ID: 13799238
    [No Abstract]   [Full Text] [Related]  

  • 19. Increase in acceleration tolerance of the rat by 2-dimethylaminoethyl p-chlorophenoyx-acetate (lucidril).
    POLIS BD
    Aerosp Med; 1962 Aug; 33():930-4. PubMed ID: 14487585
    [No Abstract]   [Full Text] [Related]  

  • 20. [Medical and psychological study of the effects of 2-dimethylaminoethyl p-acetamidobenzoate in a group of 50 children].
    FOIS A; PIERI I; MALANDRINI F; FERRI BM; ROSER OL
    Riv Clin Pediatr; 1959 Oct; 64():318-28. PubMed ID: 13823679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.